GO
Loading...

Celgene Corp

More

  • Midday Glance: Biotechnology companies Tuesday, 28 Apr 2015 | 1:50 PM ET

    Amgen Inc. rose $2.04 or 1.3 percent, to $164.42. Biogen Idec fell $8.05 or 2.1 percent, to $381.22. Celgene Corp. fell$. 81 or. 7 percent, to $113.91.

  • Early Glance: Biotechnology companies Tuesday, 28 Apr 2015 | 10:39 AM ET

    Amgen Inc. fell$. 23 or. 1 percent, to $162.15. Biogen Idec fell $8.74 or 2.2 percent, to $380.53. Celgene Corp. fell $1.03 or. 9 percent, to $113.69.

  • Final Glance: Biotechnology companies Monday, 27 Apr 2015 | 6:06 PM ET

    Amgen Inc. fell $5.53 or 3.3 percent, to $162.38. Biogen Idec fell $12.44 or 3.1 percent, to $389.27. Celgene Corp. fell $4.00 or 3.4 percent, to $114.72.

  • Midday Glance: Biotechnology companies Monday, 27 Apr 2015 | 1:50 PM ET

    Amgen Inc. fell $5.07 or 3.0 percent, to $162.84. Biogen Idec fell $11.37 or 2.8 percent, to $390.34. Celgene Corp. fell $3.51 or 3.0 percent, to $115.20.

  • Early Glance: Biotechnology companies Monday, 27 Apr 2015 | 11:25 AM ET

    Amgen Inc. fell $1.08 or. 6 percent, to $166.83. Biogen Idec fell $1.10 or. 3 percent, to $400.62. Celgene Corp. fell$. 50 or. 4 percent, to $118.21.

  • Final Glance: Biotechnology companies Friday, 24 Apr 2015 | 8:08 PM ET

    Amgen Inc. fell $1.26 or. 7 percent, to $167.91. Biogen Idec fell $28.57 or 6.6 percent, to $401.71. Celgene Corp. rose $2.62 or 2.3 percent, to $118.71.

  • NEW YORK, April 24- Healthcare companies on a seven-year tear have been top performers so far in 2015, helping to push broad stock indexes to record levels, but traders are now looking to protect themselves from a selloff as they await major earnings reports in the sector. Companies reporting first-quarter earnings next week include Bristol-Meyers Squibb Co,...

  • Midday Glance: Biotechnology companies Friday, 24 Apr 2015 | 1:36 PM ET

    Amgen Inc. fell $1.01 or. 6 percent, to $168.16. Biogen Idec fell $25.40 or 5.9 percent, to $404.88. Celgene Corp. rose $3.05 or 2.6 percent, to $119.14.

  • Early Glance: Biotechnology companies Friday, 24 Apr 2015 | 10:55 AM ET

    Amgen Inc. fell $1.09 or. 6 percent, to $168.08. Biogen Idec fell $26.23 or 6.1 percent, to $404.05. Celgene Corp. rose$. 79 or. 7 percent, to $116.88.

  • LONDON, April 24- AstraZeneca is getting a $450 million windfall by letting Celgene develop a prized immunotherapy drug for blood cancers but its chief executive insists the deal is about strategy, not cash. Chief Executive Pascal Soriot, however, said he had been looking for a partner in blood cancers since last year and by teaming up with U.S.-based Celgene, a...

  • LONDON, April 24- AstraZeneca has sharpened its focus on cancer drugs with two new deals as it looks beyond a hit to sales and profits from the launch of cheap copies of its popular stomach acid pill Nexium in the vital U.S. market. AstraZeneca will get an upfront payment of $450 million from Celgene, while Innate will receive an initial $250 million from...

  • Final Glance: Biotechnology companies Thursday, 23 Apr 2015 | 6:05 PM ET

    Amgen Inc. rose$. 07 or percent, to $169.17. Biogen Idec rose $6.71 or 1.6 percent, to $430.28. Celgene Corp. rose$. 55 or. 5 percent, to $116.09.

  • Midday Glance: Biotechnology companies Thursday, 23 Apr 2015 | 1:24 PM ET

    Amgen Inc. fell$. 81 or. 5 percent, to $168.29. Biogen Idec rose $5.95 or 1.4 percent, to $429.52. Celgene Corp. rose$. 39 or. 3 percent, to $115.93.

  • Early Glance: Biotechnology companies Thursday, 23 Apr 2015 | 11:02 AM ET

    Amgen Inc. fell $1.85 or 1.1 percent, to $167.25. Biogen Idec fell $1.23 or. 3 percent, to $422.34. Celgene Corp. fell$. 19 or. 2 percent, to $115.35.

  • Final Glance: Biotechnology companies Wednesday, 22 Apr 2015 | 6:13 PM ET

    Amgen Inc. rose$. 64 or. 4 percent, to $169.10. Biogen Idec rose $1.46 or. 3 percent, to $423.57. Celgene Corp. rose$. 72 or. 6 percent, to $115.54.

  • Midday Glance: Biotechnology companies Wednesday, 22 Apr 2015 | 1:39 PM ET

    Amgen Inc. rose$. 63 or. 4 percent, to $169.09. Biogen Idec fell $1.52 or. 4 percent, to $420.59. Celgene Corp. rose$. 36 or. 3 percent, to $115.18.

  • Early Glance: Biotechnology companies Wednesday, 22 Apr 2015 | 10:25 AM ET

    Amgen Inc. rose$. 66 or. 4 percent, to $169.12. Biogen Idec rose $2.39 or. 6 percent, to $424.50. Celgene Corp. rose $1.08 or. 9 percent, to $115.90.

  • Final Glance: Biotechnology companies Tuesday, 21 Apr 2015 | 6:03 PM ET

    Amgen Inc. rose $2.49 or 1.5 percent, to $168.46. Biogen Idec fell$. 81 or. 2 percent, to $422.11. Celgene Corp. rose$. 07 or. 1 percent, to $114.82.

  • Midday Glance: Biotechnology companies Tuesday, 21 Apr 2015 | 1:45 PM ET

    Amgen Inc. rose $1.98 or 1.2 percent, to $167.95. Biogen Idec fell$. 40 or. 1 percent, to $422.52. Celgene Corp. rose$. 22 or. 2 percent, to $114.97.

  • Early Glance: Biotechnology companies Tuesday, 21 Apr 2015 | 10:51 AM ET

    Amgen Inc. rose $2.26 or 1.4 percent, to $168.23. Biogen Idec rose $2.50 or. 6 percent, to $425.42. Celgene Corp. rose $1.17 or 1.0 percent, to $115.92.